SARS-CoV-2 MULTI Tests will be available for in vitro diagnostics and for research applications. The tests enable RT-qPCR-based quantification of two segments of the SARS-CoV-2 genome and a human control RNA. They are compatible with extracted RNA and crude saliva samples as well.
The list of innovative products comprises RT-qPCR-based tests for the quantification of CK-19 mRNA in RNA samples.

Detecting Rare Cells in blood and other body fluids can be a real challenge. OncoLab provides research tools that make hunting for rare circulating endothelial cells (CEC), a simple diagnostic test.
OncoLab’s CEC test is based on fluorescent immunostaining of endothelial cells after enrichment from blood samples. State-of-the-art biomarkers coupled with enhanced scanning optical systems powered by artificial intelligence enable convenient and efficient research of CEC.
The list of products comprises special blood collection tubes, tools and reagents for cell purification, proprietary immunofluorescent cocktails for staining (IF), tools and general use reagents for preparing cytology slides, microscope imaging, and image analysis.

SARS-CoV-2 COMBI Tests for the detection SARS-CoV-2, Influenza A/B, and Respiratory syncytial virus will be available for in vitro diagnostics and for research applications. The tests will enable RT-qPCR-based quantification of viral RNA and a human control RNA. They are compatible with extracted RNA and crude saliva samples as well.
Tailored tests for the detection of certain SARS-CoV-2 variants are under development as well.